Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC S23 healthcare AI phone agents automating 50-70% of inbound calls for scheduling, prior auth, and claims; $5M Emergence Capital seed Sep 2025 with 4x revenue growth competing with Nuance and Luma Health for the $200B healthcare admin voice automation market.
Prosper AI is a San Francisco-based healthcare AI voice automation company — backed by Y Combinator (S23) with $5 million in seed funding in September 2025 led by Emergence Capital — providing healthcare providers with AI phone agents that automate inbound patient call workflows including patient scheduling, balance reminders, claims status checks, benefits verification, and prior authorization status inquiries — achieving 50-70% inbound call automation rates with 99% IVR navigation accuracy. Founded in 2023 by Josep Mingot and Xavier de Gracia (MIT and Harvard alumni), Prosper AI achieved 4x revenue growth since Q2 2025, addressing the $450 billion US healthcare administrative overhead crisis where an estimated $200 billion in administrative costs come from phone-based patient-provider communication inefficiencies.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.